Vident Investment Advisory’s Celldex Therapeutics CLDX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-39,134	Closed	-$477K	–	915
2018 Q1	$477K	Buy	39,134 +10,629	+37%	+$412K	0.02%	628
2017 Q4	$1.21M	Sell	28,505 -4,496	-14%	-$193K	0.05%	350
2017 Q3	$1.42M	Buy	33,001 +1,000	+3%	+$37.5K	0.08%	321
2017 Q2	$1.19M	Buy	32,001 +16,264	+103%	+$719K	0.1%	304
2017 Q1	$852K	Buy	15,737 +2,623	+20%	+$137K	0.08%	318
2016 Q4	$696K	Buy	13,114 +2,875	+28%	+$164K	0.08%	313
2016 Q3	$620K	Buy	10,239 +196	+2%	+$12.2K	0.08%	321
2016 Q2	$661K	Buy	10,043 +3,863	+63%	+$245K	0.09%	337
2016 Q1	$350	Buy	6,180 +2,884	+88%	+$324K	0.02%	367
2015 Q4	$775K	Buy	+3,296	New	+$719K	0.1%	336